AIO 8507L
Latest Information Update: 20 Nov 2003
At a glance
- Originator Ono Pharmaceutical
- Class
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Benign prostatic hyperplasia
Most Recent Events
- 31 Aug 2003 Discontinued - Phase-I for Benign prostatic hyperplasia in United Kingdom (PO)
- 31 Aug 2003 Discontinued - Phase-II for Benign prostatic hyperplasia in Japan (PO)
- 31 Aug 2003 Discontinued - Phase-II for Benign prostatic hyperplasia in USA (PO)